Ashland
Open
$51.76
Prev. Close
$51.76
High
$51.76
Low
$51.55
Market Snapshot
$2.25B
-3.3
-0.60
$2.05B
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. The company is headquartered in Wilmington, Delaware and currently employs 2,900 full-time employees. The firm serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
Ashland's Q2 sales remained flat, with decreased net income and variable stock performance, prompting an update to their full-year sales guidance.
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. The company is headquartered in Wilmington, Delaware and currently employs 2,900 full-time employees. The firm serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
Recently from Cashu
Aerospace, Industrial Demand Lifts Specialty-Chemicals Outlook — Tailwinds for Ashland
Aerospace and industrial demand lifts outlook for specialty-chemicals suppliers Woodward revises its full-year earnings outlook upward, forecasting adjusted earnings of $8.20 to $8.60 per share and ex…
Ashland Place Appoints Jennifer Villa as Vice Chair to Enhance Strategic Direction
Ashland Place Finance Appoints Jennifer Villa as Vice Chair to Strengthen Strategic Direction Ashland Place Finance LLC, a prominent commercial aviation financing platform, announces the appointment o…
Northlake II Boosts Ashland's Industrial Market with Strategic Lease to DPR Construction
Strategic Industrial Growth: Northlake II's Impact on Ashland's Market Matan Companies, a leading industrial developer in the Mid-Atlantic region, secures a pivotal full-building lease for the final p…
Ashland's Golidocitinib Shows Promising Results in Hematology Drug Developments at ASH Meeting
Ashland Advances in Hematology with Promising Drug Developments At the forefront of innovative cancer treatment, Dizal (SSE:688192), a biopharmaceutical company, is making significant strides in its h…